Documents

in page functions

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

18 December 2008

TPP Master Table

The master table of the target product profile (TPP), product specifications, relate to the public health impact and suitability of the product. 

18 December 2008

TPP Supplementary Information

Supplementary informational for the target product profile (TPP) including general information, vaccine characteristics relevant to the TPP, contributors and WHO policy documents. 

11 December 2008

Minutes from December 2008 meeting

Minutes from the AMC Independent Assessment Committee (IAC) meeting on 11 December 2008.

30 November 2008

TPP Codebook

Codebook to assess whether a pneumococcal vaccine meets the Pneumococcal AMC Target Product Profile for regional vaccine serotype coverage.

13 November 2008

Monitoring and Evaluability Study

The report was commissioned by the Monitoring & Evaluation Subgroup of the AMC Donor Committee in August 2007. The monitoring and evaluation proposals contained in this report have been designed to enable the effectiveness, efficiency and eventual impact of this pilot AMC to be measured over time and to assist with its effective management.

03 November 2008

Minutes from November 2008 meeting

Minutes from the AMC Independent Assessment Committee (IAC) meeting on 3 November 2008.

29 October 2008

Vaccine investment strategy - Executive summary

Vaccine investment strategy - Executive summary

29 October 2008

Vaccine investment strategy - Vaccine Portfolio Analysis

GAVI Vaccine Investment Strategy --  Project Vaccine Portfolio Analysis by Applied Strategies.

20 October 2008

First GAVI Evaluation 2000-2005 - Executive Summary

This evaluation was commissioned by the GAVI Board to: identify and learn from the successes and weaknesses of GAVI in Phase 1, including how well it has evolved and learned from experience over the period 2000-2005; contribute to the refinement or adjustment of GAVI policies in the next strategic phase of work; and document the impact and to evaluate the efficiency and effectiveness of the GAVI Alliance’s use of resources during Phase 1.

20 October 2008

First GAVI Evaluation 2000-2005

This evaluation was commissioned by the GAVI Board to: identify and learn from the successes and weaknesses of GAVI in Phase 1, including how well it has evolved and learned from experience over the period 2000-2005; contribute to the refinement or adjustment of GAVI policies in the next strategic phase of work; and document the impact and to evaluate the efficiency and effectiveness of the GAVI Alliance’s use of resources during Phase 1.

Searching... One moment please

1 - 10 of 21 matches Page: 1 2 3 
 



close icon

modal window here